| Literature DB >> 27252773 |
Osvaldo Chiara1, Emanuele di Fratta2, Anna Mariani2, Bertuzzi Michaela3, Lucia Prestini3, Fabrizio Sammartano2, Stefania Cimbanassi2.
Abstract
BACKGROUND: An option for emergency control of pelvic hemorrhage is Extra-peritoneal Pelvic Packing (EPP), which addresses the retroperitoneal source of exsanguination in pelvic fractures. The aim of this study was to demonstrate the efficacy of early EPP in reducing mortality due to hemorrhage from pelvic fractures, and to evaluate the impact of packing on transfusion requirements within the first 24 h and ICU length of stay (ICU-LOS). All data pertaining trauma patients admitted from October 2002 and December 2103 with hemodynamic instability and pelvic fractures were selected from the Hospital Trauma Registry. Patients with severe brain injury and bleeding from extra-pelvic sources were excluded. Patient population was divided into two groups: EPP group, including patients admitted from 2009 to 2013, with EPP as part of the treatment algorithm, and NO-EPP group, from 2002 to 2008, without EPP as atherapeutic option. Descriptive statistical analysis was performed on allpatients. Twenty-five patients of each group with similar features were matched using Propensity Score Analysis (PSA).Entities:
Keywords: Extra-peritoneal pelvic packing; Hemodynamic instability; Pelvic fracture; Propensity score analysis
Year: 2016 PMID: 27252773 PMCID: PMC4888211 DOI: 10.1186/s13017-016-0077-2
Source DB: PubMed Journal: World J Emerg Surg ISSN: 1749-7922 Impact factor: 5.469
Fig. 1Treatment algorithm of patients with pelvic fracture and hemodynamic instability since 2009 at Niguarda Trauma Centre
Mechanisms of injury in the two groups
| Mechanism | EPP | NO-EPP |
|---|---|---|
| Car | 2 (6.6) | 5 (10.4) |
| Motorcycle | 7 (23.3) | 10 (20.8) |
| Bicycle | 2 (6.6) | 8 (16.6) |
| Pedestrian | 9 (30) | 10 (20.8) |
| Fall | 10 (33.3) | 13 (27.1) |
General characteristics of group 1 and 2 patients selected from Trauma Registry
| EPP Group ( | NO-EPP Group ( |
| |
|---|---|---|---|
| Age (years) | 55.3 ± 21.8 | 48.5 ± 20.8 | 0.1393 |
| ISS | 44.93 ± 10.06 | 40.57 ± 15.53 | 0.142 |
| Tile Young & Burgess | 0.076 | ||
| A APCI-LCI | 1 (2 %) | 5 (10 %) | |
| B APCI-II, LCI-III | 9 (29 %) | 24 (50 %) | |
| C APCIII,VS,CM | 20 (69 %) | 19 (40 %) | |
| Extra-pelvic injuries | 23 (77 %) | 33 (70 %) | 0.626 |
| Mortality | 10 (33 %) | 21 (49 %) | 0.092 |
Potential confounders in patients matched with Propensity Score Analysis and calculated Propensity Scores
| EPP GROUP | NO-EPP GROUP | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | Age | ISS | Tile/Y&B | Extra-pelvic injuries yes/no | Propensity Score | ID | Age | ISS | Tile/YB | Extra-pelvic injuries yes/no | Propensity Score |
| P.D. | 19 | 50 | C1/APCIII | yes | 0.27 | P.M. | 15 | 68 | C3/CM | Yes | 0.27 |
| C.G. | 46 | 50 | C2/VS | yes | 0.52 | B.E. | 62 | 59 | C3/CM | Yes | 0.48 |
| T.A. | 77 | 41 | B3/LCIII | yes | 0.44 | P.A. | 85 | 50 | B3/LCIII | No | 0.39 |
| A.J. | 20 | 43 | C2/VS | yes | 0.44 | F.S. | 35 | 41 | C2/VS | No | 0.41 |
| P.G. | 60 | 48 | C1/APCIII | yes | 0.51 | P.M. | 38 | 45 | C2/VS | yes | 0.52 |
| E.A. | 85 | 38 | B2/LCI | yes | 0.55 | B.M | 46 | 38 | C2/VS | No | 0.50 |
| P.A. | 79 | 41 | B2/LCI | yes | 0.35 | I.C. | 52 | 25 | B2/LCI | No | 0.36 |
| A.L. | 59 | 45 | C1/APCIII | yes | 0.40 | M.P. | 41 | 25 | B3/LCIII | No | 0.40 |
| V.M. | 55 | 38 | C1/APCIII | yes | 0.59 | F.G. | 63 | 25 | B3/LCIII | yes | 0.66 |
| S.G. | 76 | 43 | B2/LCII | yes | 0.31 | C.P. | 42 | 50 | B3/LCIII | yes | 0.29 |
| C.A. | 63 | 34 | C1/VS | yes | 0.54 | Z.F. | 35 | 32 | C2/VS | No | 0.50 |
| C.E. | 84 | 38 | B3/LCIII | yes | 0.51 | A.F. | 36 | 32 | C2/VS | yes | 0.51 |
| L.P. | 72 | 50 | B2/LCII | yes | 0.35 | F.A. | 80 | 43 | B2/LCI | No | 0.34 |
| I.A. | 27 | 57 | C1/VS | yes | 0.16 | L.P. | 30 | 59 | C1/APCIII | yes | 0.15 |
| P.L. | 69 | 38 | B2/LCII | yes | 0.32 | T.D. | 38 | 34 | B2/LCII | yes | 0.33 |
| M.P. | 77 | 25 | C2/VS | no | 0.79 | C.I. | 65 | 26 | C3/CM | No | 0.80 |
| B.A. | 52 | 34 | C2/VS | no | 0.58 | G.P. | 60 | 59 | C2/CM | yes | 0.50 |
| N.B. | 69 | 25 | B2/LCI | No | 0.46 | C.A. | 29 | 59 | C3/CM | yes | 0.43 |
| P.L. | 70 | 38 | C2/VS | yes | 0.76 | A.G | 81 | 26 | C2/VS | No | 0.80 |
| G.G. | 53 | 25 | C1/APCIII | no | 0.58 | G.R. | 62 | 19 | B2/LCI | No | 0.48 |
| M.L. | 34 | 43 | C2/VS | yes | 0.52 | M.G | 79 | 29 | B2/LCI | No | 0.47 |
| A.A. | 82 | 38 | C2/CM | yes | 0.36 | B.G. | 83 | 75 | C1/APCIII | yes | 0.36 |
| P.M. | 80 | 29 | C3/CM | no | 0.84 | C.M | 88 | 41 | C2/VS | yes | 0.81 |
| C.M. | 55 | 25 | B2/LCII | no | 0.38 | R.D. | 40 | 57 | C3/CM | yes | 0.37 |
| G.J. | 24 | 41 | C2/VS | yes | 0.48 | G.Z. | 36 | 45 | C1/APCIII | yes | 0.40 |
Comparisons of the two groups matched with Propensity Score Analysis. Continuous data are expressed as mean values ± SD
| EPP Group (25 pts) | NO-EPP Group (25 pts) |
| |
|---|---|---|---|
| Base Excess (mEq/L) | −4.33 ± 3.78 | −4.88 ± 3.38 | 0.29 |
| Lactate (mmol/L) | 5.18 ± 2.55 | 5.80 ± 3.38 | 0.23 |
| INR | 1.91 ± 090 | 1.46 ± 0.33 | 0.03 |
| Arterial bleeding | 22 (88 %) | 19 (76 %) | - |
| Number of total deaths | 7 (28 %) | 13 (52 %) | 0.01 |
| Deaths >24 h | 2 (8 %) | 0 | - |
| Deaths < 24 h | 5 (20 %) | 13 (52 %) | 0.03 |
| Hours from admission to death | 122.8 ± 63.11 | 7.38 ± 10.43 | 0.003 |
| n. of angio-embolizations | 21 (84 %) | 14 (56 %) | 0.05 |
| n. of PRBCs < 24 h | 13.00 ± 11.00 | 14.10 ± 11.00 | 0.71 |
| ICU-LOS (days) | 19.80 ± 12.60 | 18.70 ± 11.00 | 0.73 |